BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1942124)

  • 1. Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver.
    Vorce RL; Goodman JI
    J Toxicol Environ Health; 1991 Nov; 34(3):385-95. PubMed ID: 1942124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential DNase I hypersensitivity of ras oncogenes in B6C3F1, C3H/He, and C57BL/6 mouse liver.
    Vorce RL; Goodman JI
    Mol Toxicol; 1989; 2(3):187-97. PubMed ID: 2487756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Mol Toxicol; 1989; 2(2):99-116. PubMed ID: 2702305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypomethylation of ras oncogenes in chemically induced and spontaneous B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    J Toxicol Environ Health; 1991 Nov; 34(3):367-84. PubMed ID: 1658350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered methylation of ras oncogenes in benzidine-induced B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Toxicol Appl Pharmacol; 1989 Sep; 100(3):398-410. PubMed ID: 2551075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesis.
    Buchmann A; Karcier Z; Schmid B; Strathmann J; Schwarz M
    Mutat Res; 2008 Feb; 638(1-2):66-74. PubMed ID: 17928010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice.
    Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW
    Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the methylation status of ras oncogenes in B6C3F1 mouse liver tumors.
    Vorce RL; Goodman JI
    Prog Clin Biol Res; 1990; 331():335-43. PubMed ID: 2179961
    [No Abstract]   [Full Text] [Related]  

  • 9. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene.
    Goodrow T; Reynolds S; Maronpot R; Anderson M
    Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis.
    Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R
    Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypomethylation of DNA: a possible epigenetic mechanism involved in tumor promotion.
    Counts JL; Goodman JI
    Prog Clin Biol Res; 1995; 391():81-101. PubMed ID: 8532739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the methylation status of the 5' flanking region of Ha-ras in B6C3F1, C3H/He and C57BL/6 mouse liver.
    Counts JL; Goodman JI
    Cancer Lett; 1993 Dec; 75(2):129-36. PubMed ID: 8293423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the methylation status and expression of the raf oncogene in phenobarbital-induced and spontaneous B6C3F1 mouse liver tumors.
    Ray JS; Harbison ML; McClain RM; Goodman JI
    Mol Carcinog; 1994 Mar; 9(3):155-66. PubMed ID: 7908202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the Ha-, Ki-, and N-ras genes in chemically induced liver tumors from CD-1 mice.
    Manam S; Storer RD; Prahalada S; Leander KR; Kraynak AR; Ledwith BJ; van Zwieten MJ; Bradley MO; Nichols WW
    Cancer Res; 1992 Jun; 52(12):3347-52. PubMed ID: 1596892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras mutations in 2-acetylaminofluorene-induced lung and liver tumors from C3H/HeJ and (C3H x A/J)F1 mice.
    Wang Y; Wang Y; Stoner G; You M
    Cancer Res; 1993 Apr; 53(7):1620-4. PubMed ID: 8453632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational activation of the c-Ha-ras gene in liver tumors of different rodent strains: correlation with susceptibility to hepatocarcinogenesis.
    Buchmann A; Bauer-Hofmann R; Mahr J; Drinkwater NR; Luz A; Schwarz M
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):911-5. PubMed ID: 1992483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression of cellular oncogenes during hepatocarcinogenesis in rats].
    Li S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Apr; 12(2):121-5. PubMed ID: 2143111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.
    Jiang N; Zhan F; Cao L; Yao K; Li G
    Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low frequency of H-ras activation in naturally occurring hepatocellular tumors of C3H/HeNCr mice.
    Enomoto T; Weghorst CM; Ward JM; Anderson LM; Perantoni AO; Rice JM
    Carcinogenesis; 1993 Sep; 14(9):1939-44. PubMed ID: 8403222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.